Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
86
datasets available to search
ShareScore release 0.9.0
Dataset results
86 results for “risankizumab”
BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
ClinicalTrials.gov study NCT02047110. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.
ClinicalTrials.gov study NCT02031276. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
ClinicalTrials.gov study NCT04780516. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation
ClinicalTrials.gov study NCT03518047. IPD Sharing: YES. Countries: 1. Publications: 1.
BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03000075. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
ClinicalTrials.gov study NCT03105102. IPD Sharing: YES. Countries: 47. Publications: 8.
A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Coliti
ClinicalTrials.gov study NCT04254783. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT03398135. IPD Sharing: YES. Countries: 43. Publications: 4.
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout t
ClinicalTrials.gov study NCT06333860. IPD Sharing: YES. Countries: 12. Publications: 0.
BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02684370. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Risankizumab Long-term Remission Study
ClinicalTrials.gov study NCT04630652. IPD Sharing: NO. Countries: 1. Publications: 11.
BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT02694523. IPD Sharing: Not stated. Countries: 0. Publications: 5.
This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis
ClinicalTrials.gov study NCT02772601. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Dis
ClinicalTrials.gov study NCT04524611. IPD Sharing: YES. Countries: 31. Publications: 3.
BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
ClinicalTrials.gov study NCT02672852. IPD Sharing: YES. Countries: 0. Publications: 4.
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
ClinicalTrials.gov study NCT04435600. IPD Sharing: YES. Countries: 7. Publications: 0.
Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
ClinicalTrials.gov study NCT07166315. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy
ClinicalTrials.gov study NCT03255382. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03875508. IPD Sharing: YES. Countries: 1. Publications: 0.
Long-term remissions and marked decreases in resident memory T cells following high induction dosing with risankizumab in randomized patients with moderate-to-severe plaque psoriasis
GEO Series GSE305818. Homo sapiens. 41 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.